Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
Rupak Shivakoti(Johns Hopkins University), Breno Santos(Hospital Nossa Senhora da Conceição), Mina C. Hosseinipour, Selvamuthu Poongulali(YR Gaitonde Centre for AIDS Research and Education), Thomas Campbell(University of Colorado Anschutz Medical Campus), Wadzanai Samaneka(University of Zimbabwe), Ashwin Balagopal(Johns Hopkins University), James Hakim(University of Zimbabwe), David M. Asmuth(University of California, Davis), Srikanth Tripathy(Indian Council of Medical Research), Nikhil Gupte(Johns Hopkins University), Ian Sanne(University of the Witwatersrand), Patcharaphan Sugandhavesa(Chiang Mai University), Robert C. Bollinger(Johns Hopkins University), Sima Berendes(Johns Hopkins University), Noluthando Mwelase(University of the Witwatersrand), Sandra Wagner Cardoso(Instituto Evandro Chagas), Andrea L. Cox(Johns Hopkins University), Cecilia Kanyama, Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Wei-Teng Yang(Bridgeport Hospital), Richard D. Semba(Johns Hopkins University), Cynthia Riviere(Hôpital Necker-Enfants Malades), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Sandy Pillay(Durban University of Technology), Amita Gupta(Johns Hopkins University)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548